The Real World Evidence Conference in USA 2026, featuring the 2nd Annual EVIDENCE 360: RWE, Pricing and Market Access Summit – USA Edition, is set to be a premier event for healthcare and life sciences professionals. Taking place in Philadelphia on 08–09 June 2026, this high-level summit will bring together key stakeholders to explore the growing impact of real-world evidence (RWE) on pricing, reimbursement, and market access strategies.

A Premier Platform for Healthcare Decision-Makers

The EVIDENCE 360 Summit USA 2026 serves as a critical platform for U.S. healthcare stakeholders to examine how RWE is reshaping the landscape of healthcare decision-making. As the demand for cost-effective, outcomes-driven healthcare continues to rise, the conference gathers leading voices from:

• Pharmaceutical and biotech companies

• Payers and insurers

• Regulatory authorities

• Health Technology Assessment (HTA) bodies

• Digital health innovators

Together, these experts will address the most pressing challenges related to access, value, and evidence generation across the U.S. healthcare system.

Navigating a Transformative Era in U.S. Healthcare

The U.S. healthcare market is undergoing significant transformation, driven by factors such as:

• IRA drug price negotiations

• Increased scrutiny from the Centers for Medicare & Medicaid Services (CMS)

• Expansion of value-based care models

• AI-enabled evidence generation

• Growing demand for equity-driven healthcare outcomes

At the Real World Evidence Conference USA 2026, discussions will focus on how organizations can effectively generate, translate, and operationalize RWE to influence payer decisions and healthcare policy.

Key Focus Areas of the Summit

This senior-level, two-day summit is designed to provide actionable insights into how RWE is transforming the industry. Key themes include:

• The role of RWE in pricing and reimbursement strategies

• Enhancing market access through data-driven insights

• Leveraging AI and advanced analytics for evidence generation

• Aligning RWE with regulatory and payer expectations

• Driving equity and patient-centered outcomes

Attendees will gain practical knowledge on how to integrate RWE into their organizational strategies to improve both clinical and commercial outcomes.

Who Should Attend?

The EVIDENCE 360 USA 2026 Summit is tailored for senior professionals, including:

• Market access and HEOR leaders

• RWE and data analytics experts

• Regulatory and policy professionals

• Payer and reimbursement specialists

• Pharma and biotech executives

It provides a unique opportunity to network with industry leaders, exchange ideas, and explore innovative approaches to healthcare challenges.

Get More Details and Registration at https://veridonglobal.com/upcoming-conferences/2nd-annual-evidence-360-summit-usa-edition/2nd-annual-evidence-360-usa-registeration/ 

Transforming Healthcare Through Real-World Evidence

As real-world evidence becomes increasingly central to healthcare decision-making, the Real World Evidence Conference in USA 2026 stands out as a must-attend event. By bringing together cross-functional expertise, the summit empowers organizations to make better, faster, and more informed decisions that improve patient outcomes and system efficiency.

Join industry peers in Philadelphia this June to discover how RWE is revolutionizing evidence generation, payer engagement, and regulatory strategy in the evolving U.S. healthcare landscape.